{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:04:45Z","timestamp":1718496285880},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jdiacomp.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,4,17]],"date-time":"2016-04-17T22:46:18Z","timestamp":1460933178000},"page":"1025-1031","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mortality risk in admitted patients with diabetes mellitus according to treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Amit","family":"Akirov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0065","first-page":"S1","article-title":"Standards of medical care in diabetes - 2015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurheartj\/ehm519","article-title":"Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: A report from the Euro Heart Survey on Diabetes and the Heart","volume":"29","author":"Anselmino","year":"2008","journal-title":"European Heart Journal"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0100","doi-asserted-by":"crossref","first-page":"e005305","DOI":"10.1136\/bmjopen-2014-005305","article-title":"Undiagnosed diabetes from cross-sectional GP practice data: An approach to identify communities with high likelihood of undiagnosed diabetes","volume":"4","author":"Bagheri","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0070","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/hs1001.096194","article-title":"Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview","volume":"32","author":"Capes","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0185","series-title":"National Diabetes Statistics Report","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0190","article-title":"Mortality in individuals treated with glucose lowering agents: A large, controlled cohort study","volume":"101","author":"Claesen","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.2003.00972.x","article-title":"The impact of diabetes-related complications on healthcare costs: Results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)","volume":"20","author":"Clarke","year":"2003","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0050","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jc.2012-3042","article-title":"Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes","volume":"98","author":"Currie","year":"2013","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1258\/shorts.2011.011100","article-title":"Increased length of inpatient stay and poor clinical coding: audit of patients with diabetes","volume":"2","author":"Daultrey","year":"2011","journal-title":"JRSM Short Representative"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.2042-7158.1955.tb12043.x","article-title":"The operating characteristics of some official weight variation tests for tablets","volume":"7","author":"Dunnett","year":"1955","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1464-5491.2008.02581.x","article-title":"Glycated haemoglobin and cardiovascular outcomes in people with type 2 diabetes: A large prospective cohort study","volume":"25","author":"Elley","year":"2008","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/diab.36.7.808","article-title":"Progression of incipient diabetic retinopathy during good glycemic control","volume":"36","author":"Engerman","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0180","article-title":"Association of more negative attitude towards commencing insulin with lower glycosylated hemoglobin (HbA1c) level: A survey on insulin-na\u00efve type 2 diabetes mellitus Chinese patients","volume":"15","author":"Fu","year":"2016","journal-title":"Journal of Diabetes & Metabolic Disorder"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.numecd.2012.07.001","article-title":"The role of the care model in modifying prognosis in diabetes","volume":"23","author":"Giorda","year":"2013","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0110","doi-asserted-by":"crossref","first-page":"e0118749","DOI":"10.1371\/journal.pone.0118749","article-title":"Factors associated with untreated diabetes: Analysis of data from 20,496 participants in the Japanese national health and nutrition survey","volume":"10","author":"Goto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0160","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","author":"Green","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1353\/hpu.2011.0149","article-title":"Adults with diagnosed and untreated diabetes: Who are they? How can we reach them?","volume":"22","author":"Hill","year":"2011","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2169\/internalmedicine.50.4268","article-title":"Prevalence of type 2 diabetes among acute inpatients and its impact on length of hospital stay in Japan","volume":"50","author":"Kubo","year":"2011","journal-title":"Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0045","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1515\/CCLM.2009.346","article-title":"A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus","volume":"47","author":"Lavant","year":"2009","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0090","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2337\/dc12-2543","article-title":"Estimating the population prevalence of diagnosed and undiagnosed diabetes","volume":"36","author":"Leong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30years: Overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0195","series-title":"Key findings about the quality of care of inpatients with diabetes in England and Wales","article-title":"National Diabetes Inpatient Audit (NaDIA) \u2013 2011","author":"National Health Service","year":"2012"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/1060028014547383","article-title":"Identification of previously undiagnosed diabetes and prediabetes in the inpatient setting using risk factor and hemoglobin A1C screening","volume":"48","author":"Ochoa","year":"2014","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0165","series-title":"Symp 75th Sci Sess Am Diabetes Assoc Boston, MA","article-title":"The evaluation of lixisenatide in acute coronary syndrome\u2014the results of the ELIXA trial","author":"Pfeffer","year":"2015"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/436879","article-title":"Epigenetic changes in endothelial progenitors as a possible cellular basis for glycemic memory in diabetic vascular complications","volume":"2015","author":"Rajasekar","year":"2015","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.diabres.2006.10.004","article-title":"Total and excess bed occupancy by age, specialty and insulin use for nearly one million diabetes patients discharged from all English acute hospitals","volume":"77","author":"Sampson","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0145","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0055","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"The Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0155","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.04.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","author":"Zinman","year":"2015","journal-title":"The New England Journal of Medicine"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T20:23:23Z","timestamp":1718483003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872716301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1056872716301106"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.04.011","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality risk in admitted patients with diabetes mellitus according to treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}